Clinical Trial: Phase 1 Safety Study of ALRN-5281 in Healthy Subjects

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Randomized, Single-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety and Tolerability of ALRN-5281 Administered by Subcutaneous Injection in Healthy Adult Volunteers

Brief Summary: The primary objective of this study is to evaluate the safety and tolerability of a single dose of ALRN-5281 administered by subcutaneous injection to healthy adult volunteers.